Nexentis Announces MitoCareX Bio Achieves Key R&D Milestone, Generating a Substantially Improved Hit Molecule on the Path to Pre-Clinical Development

Nexentis Technologies Inc. (NASDAQ: NXTS) ("Nexentis" or the "Company"), a drug discovery company that also invests in solar energy assets based on the RTB (Ready to Build) business model, today ...

Nexentis Technologies Inc.: Nexentis Announces MitoCareX Bio Achieves Key R&D Milestone, Generating a Substantially Improved Hit Molecule on the Path to Pre-Clinical Development

Nexentis Technologies Inc. (NASDAQ: NXTS) ("Nexentis" or the "Company"), a drug discovery company that also invests in solar energy assets based on ...

T-Mobile US, Inc. (TMUS) Presents at J.P. Morgan 54th Annual Global Technology, Media and Communications Conference Transcript

T-Mobile US, Inc. ( TMUS) J.P. Morgan 54th Annual Global Technology, Media and Communications Conference May 18, 2026 2:50 PM EDT Good afternoon, everyone. I'm Sebastiano Petti, and I cover the ...

This Wall Street veteran thinks quantum is more than a speculative bet. Sizing up the stocks.

Troy Jensen of Cantor Fitzgerald says this technology is on the cusp of commercialization. He sees multiple winners.
DissentOpinion

Which Way, Western Marxism?

Who Paid the Pipers of Western Marxism? is an inversion of a right-wing conspiracy, in which the prominence of the Frankfurt ...